Published

Psychedelics as potent anti-inflammatory therapeutics

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Neuropharmacology
Date: 2022-08-22
Source: OpenAlex
DOI: 10.1016/j.neuropharm.2022.109232
PubMed: 36007854

Authors

Charles D. Nichols

Watch author

Derived topics and classifications

psilocybin Pharmacology Mechanism of Action Consciousness Review Article Inflammation Review Article

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

Psychedelics as potent anti-inflammatory therapeutics2022-08-22

Related papers

Convergent neuroimmune signaling underlying rapid antidepressant response to ketamine and psychedelics.Molecular psychiatry · 2026-07-28 A Systematic Review of EEG Predictors and Correlates of Psilocybin’s Treatment in DepressionUndergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal · 2026-07-27 Psilocybin produces amplified acute responses and sex-specific long-term increases in sensorimotor gating in the mGlu5 knockout mouse model of schizophreniaNeuropsychopharmacology · 2026-07-18 Evaluating psilocybin for the management of depression: a literature reviewBritish Journal of Mental Health Nursing · 2026-08-02 Advanced research eyes potential of psychedelics for complex casesMental Health Weekly · 2026-08-07 Impact of Psilocybin on Motor Function in Healthy Participants: A Phase 1, Randomised, Triple-Blind, Dose-Finding Study.CNS drugs · 2026-08-07 A suite of engineered mice for interrogating psychedelic drug actions.Nature neuroscience · 2026-08-06 Serotonergic psychedelics induce distinct patterns of metabolic activity and covariance within biologically informed rat brain networksNature Communications · 2026-08-03